The document discusses the Emprove® program from Merck KGaA, highlighting its aim to provide comprehensive information and support for materials used in life sciences, including various dossiers for material qualification and operational excellence. It outlines the structure and content of these dossiers, which cover specifications, quality management, and risk assessment, alongside an overview of product offerings in cell culture media and active pharmaceutical ingredients (APIs). The virtual meeting on June 1, 2021, focused on updates, user feedback, and the integration of new content within the Emprove® suite.
Related topics: